When PD-1 is combined with PD-L1, it can inhibit the activation and proliferation of T cells in peripheral tumor tissues and attenuate the cell-killing effect of T cells by regulating the PI3K-AKT-mTOR [24] and Ras-EMK-ERK pathways [25]. Here, CD274 is linked to neoplasm.